
New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

Cinven, Advent International and Bain Capital now have opportunity to revise their bids

Values the OTC and generics specialist at €3.6bn, with offer open until 27 February

Expands aesthetic pharma business with “best-in-class” body contouring system

Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end

Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer

Builds US presence with biotech-focused strategy specialist

Broadens its pipeline with autoimmune disease candidate due to start trials in 2018

Swiss biotech to retain control of early-stage pipeline as J&J takes minority stake in R&D spin-out

Licences four DNA damage and repair programmes with first-in-class or best-in-class potential

Deal includes pancreatic cancer therapy Onivyde which it hopes will gain first-line approval

Grows global operations to cover Europe and Latin America